| |
| |
|
| Insider
Information: |
Hearne Michael S |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,620 |
|
|
Indirect Shares
|
12,767,435 |
|
|
| Direct
Value |
$7,465,690 |
|
|
|
Indirect Value
|
$36,380,806,033 |
|
|
| Total
Shares |
12,770,055 |
|
|
| Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
20
|
3
|
|
Stock
price went up :
|
10
|
0
|
| Stock
price went down : |
10
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -17.1%
|
-97.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-03-31 |
4 |
A |
$3.60 |
$620 |
D/D |
172 |
3,662 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-03-31 |
4 |
A |
$3.63 |
$642 |
D/D |
177 |
8,979 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-08-13 |
4 |
B |
$3.65 |
$800,586 |
I/I |
219,465 |
8,958,452 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-05-28 |
4 |
A |
$3.66 |
$618 |
D/D |
169 |
3,934 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-05-24 |
4 |
B |
$3.68 |
$384,234 |
I/I |
104,403 |
9,509,893 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-04-14 |
4 |
A |
$3.71 |
$643 |
D/D |
173 |
9,152 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-04-30 |
4 |
A |
$3.77 |
$615 |
D/D |
163 |
3,572 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-05-25 |
4 |
B |
$3.77 |
$482,734 |
I/I |
127,379 |
9,637,272 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-02-15 |
4 |
A |
$3.79 |
$641 |
D/D |
169 |
8,427 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-09-04 |
4 |
B |
$3.82 |
$258,359 |
I/I |
67,552 |
9,194,673 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-12-15 |
4 |
A |
$3.83 |
$562 |
D/D |
147 |
787 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-08-14 |
4 |
B |
$3.88 |
$653,694 |
I/I |
168,669 |
9,127,121 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-09-08 |
4 |
B |
$3.90 |
$328,529 |
I/I |
84,152 |
9,278,825 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-12-30 |
4 |
A |
$3.92 |
$615 |
D/D |
157 |
6,435 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-01-31 |
4 |
A |
$3.94 |
$6,592 |
D/D |
1,675 |
8,258 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-11-13 |
4 |
A |
$3.98 |
$561 |
D/D |
141 |
506 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-09-09 |
4 |
B |
$4.01 |
$509,940 |
I/I |
126,665 |
9,405,490 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-06-15 |
4 |
A |
$4.17 |
$616 |
D/D |
148 |
4,082 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-01-14 |
4 |
A |
$4.18 |
$619 |
D/D |
148 |
6,583 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2020-11-30 |
4 |
A |
$4.23 |
$566 |
D/D |
134 |
640 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-05-26 |
4 |
B |
$4.26 |
$710,763 |
I/I |
166,932 |
9,804,204 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-06-01 |
4 |
B |
$4.29 |
$263,931 |
I/I |
59,092 |
10,049,224 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-02-26 |
4 |
A |
$4.45 |
$619 |
D/D |
139 |
3,363 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-05-27 |
4 |
B |
$4.47 |
$831,762 |
I/I |
185,928 |
9,990,132 |
1.99 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2021-01-15 |
4/A |
A |
$4.55 |
$618 |
D/D |
136 |
2,571 |
0 |
- |
|
145 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
